Skip to main content

News Archive

CAR-T immune therapy attacks ovarian cancer in mice with a single dose

Liz Ahlberg Touchstone

CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign rese

CABBI develops eco-friendly enzyme to create key chemical building blocks

Julie Wurth

Using energy from light to activate natural enzymes can help scientists create new-to-nature enzymatic reactions that support eco-friendly biomanufacturing — the production of f

Team identifies key driver of cancer cell death pathway that activates immune cells

Diana Yates

Scientists have identified a protein that plays a critical role in the action of several emerging cancer therapies.

Research collaboration turns up the heat in cancer immunotherapy

Jonathan King

The results of a recent canine cancer study by Tim Fan (ACPP/CGD), a professor of

Soil microbes help plants cope with drought, but not how scientists thought

Lauren Quinn

There’s a complex world beneath our feet, teeming with diverse and interdependent life.

Long receives honorary doctorate from University of Essex

Allie Arp

“I have been lucky enough to receive a few awards throughout my career, but none is more special to me than this.”

Three projects chosen for the IGB DEI Awards

Ananya Sen

The Diversity, Equity, and Inclusion Task Force at the Carl R. Woese Institute for Genomic Biology have awarded three projects for their DEI initiatives.

Joseph Fernandez

Ananya Sen

Joseph Fernandez is a postdoctoral researcher at the Genomics and Eco-evolution of Multi-Scale Symbioses Institute at the University of Illinois Urbana

Team develops all-species coronavirus test

Diana Yates

In an advance that will help scientists track coronavirus variants in wild and domesticated animals, researchers report they can now detect exposure to the SARS-Co

New insights into the structural changes associated with osteoarthritis

Ananya Sen

Osteoarthritis is the most common degenerative joint disease, affecting 22% of adults over 40 globally.

Potential breakthrough treatment for cystic fibrosis enters clinical trial

Carle Illinois College of Medicine

Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis.